Who has invested in Elucid?

Elevage Medical Technologies are named among the investors backing Elucid.

Elucid Funding: $121M Raised, Series C (2023)

Elucid funding overview

Elucid is a Healthtech company based in Boston, Massachusetts. Elucid has raised $121M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series C announced in November 2023. The round record for Elucid runs through 2023; nothing later has been disclosed. Investors on record include Elevage Medical Technologies.

Elucid at a glance

Total raised: $121M
Latest round: Series C
Latest round date: November 2023
Industry: Healthtech
Headquarters: Boston, Massachusetts
Notable investors: Elevage Medical Technologies

Frequently asked about Elucid funding

How much has Elucid raised?: Elucid has raised $121M in total disclosed funding across the rounds on record.
Who has invested in Elucid?: Elevage Medical Technologies are named among the investors backing Elucid.
What was the latest Elucid funding round?: The most recent disclosed round is a Series C, announced in November 2023.
Where is Elucid based?: Elucid is based in Boston, Massachusetts.
What sector does Elucid operate in?: Elucid is tracked under Healthtech from Boston, Massachusetts, with $121M in disclosed funding.
When did Elucid last raise?: The last disclosed Elucid round closed in November 2023 at Series C.

Elucid totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related Healthtech companies in Boston below to benchmark round size and investor mix.

Elucid Funding: $121M Raised, Series C (2023)

Elucid funding overview

Elucid at a glance

Frequently asked about Elucid funding

Companies related to Elucid (40)

Browse related funding lists (6)